1. Home
  2. SD vs BWAY Comparison

SD vs BWAY Comparison

Compare SD & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SandRidge Energy Inc.

SD

SandRidge Energy Inc.

HOLD

Current Price

$14.34

Market Cap

562.7M

Sector

Energy

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$15.80

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SD
BWAY
Founded
2006
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
562.7M
450.8M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
SD
BWAY
Price
$14.34
$15.80
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
1
2
Target Price
$15.00
$13.25
AVG Volume (30 Days)
417.0K
171.8K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
3.21%
N/A
EPS Growth
12.43
N/A
EPS
1.90
N/A
Revenue
N/A
N/A
Revenue This Year
$12.65
$309.69
Revenue Next Year
$1.75
$26.21
P/E Ratio
$7.88
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$9.07
$7.84
52 Week High
$18.45
$26.63

Technical Indicators

Market Signals
Indicator
SD
BWAY
Relative Strength Index (RSI) 32.48 56.45
Support Level $13.58 $14.56
Resistance Level $14.83 $16.63
Average True Range (ATR) 0.55 0.74
MACD -0.13 0.57
Stochastic Oscillator 14.29 91.31

Price Performance

Historical Comparison
SD
BWAY

About SD SandRidge Energy Inc.

SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. The company's primary areas of operation are the Mid-Continent in Oklahoma and Kansas.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: